An atomistic perspective on antibody-dependent cellular cytotoxicity quenching by core-fucosylation of IgG1 Fc N-glycans from enhanced sampling molecular dynamics
- PMID: 31829411
- DOI: 10.1093/glycob/cwz101
An atomistic perspective on antibody-dependent cellular cytotoxicity quenching by core-fucosylation of IgG1 Fc N-glycans from enhanced sampling molecular dynamics
Abstract
The immunoglobulin type G (IgG) Fc N-glycans are known to modulate the interaction with membrane-bound Fc γ receptors (FcγRs), fine-tuning the antibody's effector function in a sequence-dependent manner. Particularly interesting in this respect are the roles of galactosylation, which levels are linked to autoimmune conditions and aging, of core fucosylation, which is known to reduce significantly the antibody-dependent cellular cytotoxicity (ADCC), and of sialylation, which also reduces antibody-dependent cellular cytotoxicity (ADCC) but only in the context of core-fucosylation. In this article, we provide an atomistic level perspective through enhanced sampling computer simulations, based on replica exchange molecular dynamics (REMD), to understand the molecular determinants linking the Fc N-glycans sequence to the observed IgG1 function. Our results indicate that the two symmetrically opposed N-glycans interact extensively through their core trimannose residues. At room temperature, the terminal galactose on the α (1-6) arm is restrained to the protein through a network of interactions that keep the arm outstretched; meanwhile, the α (1-3) arm extends toward the solvent where a terminal sialic acid remains fully accessible. We also find that the presence of core fucose interferes with the extended sialylated α (1-3) arm, altering its conformational propensity and as a consequence of steric hindrance, significantly enhancing the Fc dynamics. Furthermore, structural analysis shows that the core-fucose position within the Fc core obstructs the access of N162 glycosylated FcγRs very much like a "door-stop," potentially decreasing the IgG/FcγR binding free energy. These results provide an atomistic level-of-detail framework for the design of high potency IgG1 Fc N-glycoforms.
Keywords: ADCC; Fc-N-glycans; IgG1; REMD; molecular dynamics.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa.Sci Rep. 2017 Oct 23;7(1):13780. doi: 10.1038/s41598-017-13845-8. Sci Rep. 2017. PMID: 29062024 Free PMC article.
-
Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies.MAbs. 2019 Jul;11(5):826-836. doi: 10.1080/19420862.2019.1608143. Epub 2019 May 8. MAbs. 2019. PMID: 30990348 Free PMC article.
-
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans.Genes Cells. 2011 Nov;16(11):1071-80. doi: 10.1111/j.1365-2443.2011.01552.x. Genes Cells. 2011. PMID: 22023369 Free PMC article.
-
Terminal sugars of Fc glycans influence antibody effector functions of IgGs.Curr Opin Immunol. 2008 Aug;20(4):471-8. doi: 10.1016/j.coi.2008.06.007. Epub 2008 Jul 17. Curr Opin Immunol. 2008. PMID: 18606225 Review.
-
The "less-is-more" in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity.MAbs. 2018 Jul;10(5):693-711. doi: 10.1080/19420862.2018.1466767. MAbs. 2018. PMID: 29733746 Free PMC article. Review.
Cited by
-
Effects of glycans and hinge on dynamics in the IgG1 Fc.J Biomol Struct Dyn. 2024;42(22):12571-12579. doi: 10.1080/07391102.2023.2270749. Epub 2023 Oct 28. J Biomol Struct Dyn. 2024. PMID: 37897185 Free PMC article.
-
Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions.Exp Suppl. 2021;112:303-340. doi: 10.1007/978-3-030-76912-3_10. Exp Suppl. 2021. PMID: 34687015
-
Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition.bioRxiv [Preprint]. 2020 May 1:2020.04.07.030445. doi: 10.1101/2020.04.07.030445. bioRxiv. 2020. Update in: Sci Rep. 2020 Sep 14;10(1):14991. doi: 10.1038/s41598-020-71748-7. PMID: 32511307 Free PMC article. Updated. Preprint.
-
Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.Sci Rep. 2020 Sep 14;10(1):14991. doi: 10.1038/s41598-020-71748-7. Sci Rep. 2020. PMID: 32929138 Free PMC article.
-
Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain.PLoS One. 2020 Aug 5;15(8):e0237295. doi: 10.1371/journal.pone.0237295. eCollection 2020. PLoS One. 2020. PMID: 32756606 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources